Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism-Reference-Cited by-同舟云学术

Targeting Bone Alleviates Osteoarthritis in Osteopenic Mice and Modulates Cartilage Catabolism

Published:2012-03-14 Issue:3 Volume:7 Page:e33543
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Funck-Brentano Thomas,Lin Hilène,Hay Eric,Ah Kioon Marie-Dominique,Schiltz Corinne,Hannouche Didier,Nizard Rémy,Lioté Frédéric,Orcel Philippe,de Vernejoul Marie-Christine,Cohen-Solal Martine Esther

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Role of subchondral bone in the initiation and progression of cartilage damage.;EL Radin;Clin Orthop Relat Res,1986

2. Response of joints to impact loading. 3. Relationship between trabecular microfractures and cartilage degeneration.;EL Radin;J Biomech,1973

3. Changes in articular cartilage and subchondral bone histomorphometry in osteoarthritic knee joints in humans.;D Bobinac;Bone,2003

4. Subchondral cystlike lesions develop longitudinally in areas of bone marrow edema-like lesions in patients with or at risk for knee osteoarthritis: detection with MR imaging–the MOST study.;MD Crema;Radiology,2010

5. Change in MRI-detected subchondral bone marrow lesions is associated with cartilage loss: the MOST Study. A longitudinal multicentre study of knee osteoarthritis.;FW Roemer;Ann Rheum Dis,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of administration of calcitonin gene-related peptide receptor antagonist on attenuation of pain and progression in osteoarthritis;Scientific Reports;2023-09-16

2. Enhanced Bone Remodeling After Fracture Priming;Calcified Tissue International;2021-10-19

3. OA foundations – experimental models of osteoarthritis;Osteoarthritis and Cartilage;2021-09

4. Inhibition of sphingosine 1-phosphate protects mice against chondrocyte catabolism and osteoarthritis;Osteoarthritis and Cartilage;2021-09

5. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date;Drug Design, Development and Therapy;2021-07